Trials / Completed
CompletedNCT01616290
Pilot Study of PRT-201 Following Angioplasty in Patients With Peripheral Artery Disease (PAD)
Open-Label, Dose-Escalation, Pilot Study of PRT-201 Administered Following Angioplasty in Patients With Peripheral Artery Disease in the Lower Extremity
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Proteon Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if it is safe and feasible to apply PRT-201 to the adventitia of arteries following successful angioplasty (PTA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PRT-201 | 0.03, 1, or 3 mg single adventitial administration |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-06-01
- Completion
- 2015-07-01
- First posted
- 2012-06-11
- Last updated
- 2015-08-11
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01616290. Inclusion in this directory is not an endorsement.